Solara Active Pharma Sciences Limited, a manufacturer of pharmaceutical products, announced the appointment of Jitesh Devendra as Managing Director of the company, with effect from April 29, 2022. He succeeds Rajender Juvvadi Rao, who has resigned from the role of Managing Director & CEO and Director of the Company.
According to the company’s exchange filing, “The Board of Directors of the Company, pursuant to the recommendation by the Nomination and Remuneration Committee, approved the appointment of Mr. Jitesh Devendra as Managing Director of the Company with effect from April 29, 2022, subject to the approval of the shareholders of the Company.”
Jitesh holds an MBA with specialization in International Business and Buyer Behaviour; Bachelor’s Degree in Commerce from University of Madras, Loyola College, Chennai, and holds a Diploma in Sales & Marketing from National Institute of Sales, Chennai.
Jitesh has more than 22 years of experience in the pharmaceutical space covering API and Formulations. He had the opportunity of leading a B2B as well as a B2C business. The core of his experience is B2B focused on Contract Development and Manufacturing plus Out licensing. Jitesh led the North America API business, as well as managed the Formulations P& L business of erstwhile Shasun Pharmaceuticals Limited, which later known as Strides Shasun and now Strides Pharma Science. His efforts have led the Division into new markets in North America; maintained business relationships and introduction of new Products for out-licensing and partnership. Post demerger of Strides, Jitesh was appointed as Managing Director of Solara Active Pharma Sciences Limited. Later Jitesh resigned from Sciara on August 03, 2020.
Jitesh is also a Director on the Board of Axxelent Pharma Science Private Limited, Shasun Leasing & Finance Private Limited and Coensus Pharma Private Limited.
